Absci (ABSI) Accounts Payables (2020 - 2026)
Absci (ABSI) reported Accounts Payables of $17.3 million for Q1 2026, up 249.91% on a YoY basis from $4.9 million in Q1 2025, and down 10.53% sequentially from $19.3 million in Q4 2025.
Absci (ABSI) Accounts Payables (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Accounts Payables data on file, last reported at $17.3 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 249.91% year-over-year to $17.3 million; the trailing twelve-month figure through Mar 2026 stood at $17.3 million (up 249.91% YoY), and the FY2025 full-year result was $19.3 million, up 85.17% from the prior year.
- Accounts Payables declined to $17.3 million in Q1 2026, from $19.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $19.3 million in Q4 2025 to a low of $1.5 million in Q4 2023.
- A 5-year average of $5.5 million and a median of $2.4 million in 2022 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables tumbled 71.32% in 2023 and jumped 595.21% in 2024, its largest moves.
- Tracing ABSI's Accounts Payables over 5 years: stood at $2.4 million in 2022, then plunged by 37.69% to $1.5 million in 2023, then jumped by 595.21% to $10.4 million in 2024, then jumped by 85.17% to $19.3 million in 2025, then decreased by 10.53% to $17.3 million in 2026.
- Business Quant data shows ABSI's Accounts Payables at $17.3 million in Q1 2026, $19.3 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 17.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.31 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.93 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 5.47 Mn |
| Mar 31, 2022 | 6.74 Mn |
| Dec 31, 2021 | 8.39 Mn |
| Sep 30, 2021 | 6.37 Mn |
| Jun 30, 2021 | 9.00 Mn |